Skip to content

reSET® Introductory Access Limited Version 1

by Pear Therapeutics, Inc.

reSET Introductory Access Limited Version 1, a mental health/function therapeutic software (FDA Class II; FDA product code PWE, Computerized Behavioral Therapy Device For Psychiatric Disorders) made by Pear Therapeutics, Inc., was granted FDA De Novo DEN160018 on 14 Sep 2017 and listed in FDA GUDID on 25 Aug 2019 (UDI-DI 10851580008132); the registry lists it as not in commercial distribution (GUDID) as of 23 Oct 2026.

Active United States. Also listed in GUDID (US), not in commercial distribution.

De Novo

Valid until

No expiry

De Novo grant is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

De Novo DEN160018

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number10851580008132 UDI-DI Date25 Aug 2019ListedStatusListed GUDID: not in commercial distribution
United StatesFDA De NovoDENG from GUDID De Novo granted · Direct NumberDEN160018 Date14 Sep 2017DecidedStatusActive

Official records

From the FDA record

Device description
reSET® is a prescription-only digital therapy intended to deliver cognitive behavioral therapy (CBT) to patients with substance use disorder (SUD). The Introductory Access Limited Version provides limited access to the reSET product.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA De Novo DEN160018 decided 14 Sep 2017 Active
  • FDA GUDID UDI-DI 10851580008132 listed 25 Aug 2019 Listed

Timeline

2 dated events

  1. Granted FDA De Novo DEN160018
  2. Listed FDA GUDID 10851580008132

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA De Novo Active

Specification

GUDID

Trade name
reSET® Introductory Access Limited Version
Generic name
Mental health/function therapeutic software, screen-viewed
Model / reference
1
Primary DI / UDI-DI
10851580008132
De Novo Number
FDA product code
PWE
GMDN term
Mental health/function therapeutic software, screen-viewed
Device class
Class II
Regulation number
882.5801
GUDID distribution status
Not in Commercial Distribution

Other devices from Pear Therapeutics, Inc.

See all devices from Pear Therapeutics, Inc. →

Properties

  • Prescription use
  • Lot / batch number
Other properties (13, all answered No)